Stock overview
Halozyme Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
HALOZYME THERAPEUTICS INC (HALO) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $112.89
- · HALO
- Tracked holders
- 3 funds
- Latest available 13F per fund
HALO · USD
Price
$112.89
+$74.36
(+192.99%)
over selected range
Close · Sep 28, 2026
Market open
1255 stored daily closes
$112.89
Sep 28, 2026
- Range low
- $30.28
- Range high
- $115.22
- Observations
- 1255
- Session date
- Sep 28, 2026
Sep 28, 2021–Sep 28, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −1% 26'Q2 | $57,862,898 | 0.13% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −35% 26'Q2 | $37,539,153 | 0.05% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+23% 26'Q2 | $4,960,440 | 0.11% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market